{"title":"Associated factors for benign prostatic hyperplasia in patients with bladder calculi.","authors":"Junjie Lu, Wanting Gao, Chunyang Fei, Wenqiang Liao, Gaoming Hou, Yuxue Lin, Wenwang Rao, Qingtao Yang, Xuxia Sui","doi":"10.1177/03915603251318869","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>A retrospective study was performed to identify potential metabolic abnormalities and inflammatory abnormalities associated with benign prostatic hyperplasia (BPH) secondary to bladder calculi.</p><p><strong>Materials and methods: </strong>This study enrolled 646 patients with bladder calculi between 2008 and 2022, including 314 patients with benign prostatic hyperplasia (BPH) and 332 without BPH. Demographic characteristics, serum biochemical parameters, prostate volume, maximum bladder calculus diameter, and randomized urinary metabolic profiles were compared between the two groups.</p><p><strong>Results: </strong>BPH was associated with increased aspartate aminotransferase/alanine aminotransferase (mean 1.2 vs 1.1, <i>P</i> < 0.05), lower cholinesterase (mean 7240.5 vs 7778.4, <i>P</i> < 0.01), increased systolic pressure (mean 137.2 vs 133.4, <i>P</i> < 0.01). Patients with BPH were significantly older and had higher systolic blood pressure compared to non-BPH patients. BPH group exhibited significantly lower levels of albumin/globulin ratio, cholinesterase, phosphorus, triglycerides, platelet count, neutrophil count, and white blood cell count, while demonstrating higher aspartate aminotransferase/alanine aminotransferase ratio, mean corpuscular volume, monocyte ratio, and urinary red blood cell count. Prostate volume was proportional to body weight and crystal count. Lower phosphorus (OR = 0.207; 95%CI = 0.068, 0.635; <i>P</i> < 0.01) and higher age (OR = 1.065; 95%CI = 1.041, 1.090; <i>P</i> < 0.001) were associated with BPH.</p><p><strong>Conclusions: </strong>Advanced age was identified as a significant risk factor for prostate hyperplasia in patients with bladder calculi, whereas elevated phosphorus levels emerged as a protective factor. The pathogenesis of BPH secondary to bladder calculi appears to be multifactorial, primarily influenced by metabolic abnormalities and inflammatory processes. These findings provide valuable insights for the clinical assessment and management of BPH secondary to bladder calculi.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"3915603251318869"},"PeriodicalIF":0.8000,"publicationDate":"2025-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urologia Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/03915603251318869","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: A retrospective study was performed to identify potential metabolic abnormalities and inflammatory abnormalities associated with benign prostatic hyperplasia (BPH) secondary to bladder calculi.
Materials and methods: This study enrolled 646 patients with bladder calculi between 2008 and 2022, including 314 patients with benign prostatic hyperplasia (BPH) and 332 without BPH. Demographic characteristics, serum biochemical parameters, prostate volume, maximum bladder calculus diameter, and randomized urinary metabolic profiles were compared between the two groups.
Results: BPH was associated with increased aspartate aminotransferase/alanine aminotransferase (mean 1.2 vs 1.1, P < 0.05), lower cholinesterase (mean 7240.5 vs 7778.4, P < 0.01), increased systolic pressure (mean 137.2 vs 133.4, P < 0.01). Patients with BPH were significantly older and had higher systolic blood pressure compared to non-BPH patients. BPH group exhibited significantly lower levels of albumin/globulin ratio, cholinesterase, phosphorus, triglycerides, platelet count, neutrophil count, and white blood cell count, while demonstrating higher aspartate aminotransferase/alanine aminotransferase ratio, mean corpuscular volume, monocyte ratio, and urinary red blood cell count. Prostate volume was proportional to body weight and crystal count. Lower phosphorus (OR = 0.207; 95%CI = 0.068, 0.635; P < 0.01) and higher age (OR = 1.065; 95%CI = 1.041, 1.090; P < 0.001) were associated with BPH.
Conclusions: Advanced age was identified as a significant risk factor for prostate hyperplasia in patients with bladder calculi, whereas elevated phosphorus levels emerged as a protective factor. The pathogenesis of BPH secondary to bladder calculi appears to be multifactorial, primarily influenced by metabolic abnormalities and inflammatory processes. These findings provide valuable insights for the clinical assessment and management of BPH secondary to bladder calculi.
目的:进行一项回顾性研究,以确定继发于膀胱结石的良性前列腺增生(BPH)的潜在代谢异常和炎症异常。材料与方法:本研究纳入2008 - 2022年间646例膀胱结石患者,其中良性前列腺增生(BPH)患者314例,非BPH患者332例。比较两组患者的人口学特征、血清生化指标、前列腺体积、最大膀胱结石直径和随机尿液代谢特征。结果:前列腺增生与天冬氨酸转氨酶/丙氨酸转氨酶升高相关(平均1.2 vs 1.1, P P P P P P P P)。结论:高龄被认为是膀胱结石患者前列腺增生的一个重要危险因素,而磷水平升高则是一个保护因素。继发于膀胱结石的前列腺增生的发病机制似乎是多因素的,主要受代谢异常和炎症过程的影响。这些发现为膀胱结石继发性前列腺增生的临床评估和治疗提供了有价值的见解。